We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROC icon
1926
Archrock
AROC
$5.8B
$6.38M ﹤0.01%
736,403
+18,777
+3% +$137K
SCS
1927
DELISTED
Steelcase
SCS
$6.38M ﹤0.01%
470,593
-13,459
-3% -$165K
RDUS
1928
DELISTED
Radius Health, Inc.
RDUS
$6.37M ﹤0.01%
356,605
+16,005
+5% +$240K
PFS icon
1929
Provident Financial Services
PFS
$3.19B
$6.37M ﹤0.01%
354,530
-856
-0.2% -$13K
EGIO
1930
DELISTED
Edgio, Inc. Common Stock
EGIO
$6.36M ﹤0.01%
39,817
-12,574
-24% -$2.3M
INVA icon
1931
Innoviva
INVA
$1.48B
$6.34M ﹤0.01%
511,961
+1,304
+0.3% +$14.1K
FNB icon
1932
FNB Corp
FNB
$6.75B
$6.34M ﹤0.01%
667,083
+31,393
+5% +$266K
CALM icon
1933
Cal-Maine
CALM
$3.99B
$6.27M ﹤0.01%
167,142
+25,855
+18% +$995K
VIR icon
1934
Vir Biotechnology
VIR
$1.49B
$6.26M ﹤0.01%
233,941
-95,707
-29% -$3.11M
SMCI icon
1935
Super Micro Computer
SMCI
$20.1B
$6.26M ﹤0.01%
1,976,350
+5,110
+0.3% +$14.4K
YMAB
1936
DELISTED
Y-mAbs Therapeutics
YMAB
$6.26M ﹤0.01%
126,370
+7,101
+6% +$328K
FBM
1937
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$6.24M ﹤0.01%
324,631
-89,018
-22% -$1.57M
BRMK
1938
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$6.21M ﹤0.01%
608,464
+9,685
+2% +$98.7K
RWT
1939
Redwood Trust
RWT
$594M
$6.2M ﹤0.01%
706,444
-1,239,121
-64% -$10.7M
YEXT icon
1940
Yext
YEXT
$574M
$6.19M ﹤0.01%
393,946
+4,670
+1% +$79.9K
AER icon
1941
AerCap
AER
$23.8B
$6.18M ﹤0.01%
135,666
-109,752
-45% -$3.83M
HBNC icon
1942
Horizon Bancorp
HBNC
$1.04B
$6.17M ﹤0.01%
389,366
-69,519
-15% -$952K
TNC icon
1943
Tennant Co
TNC
$1.26B
$6.17M ﹤0.01%
87,984
+6,221
+8% +$408K
USPH icon
1944
US Physical Therapy
USPH
$1.22B
$6.17M ﹤0.01%
51,299
-2,730
-5% -$275K
EVF
1945
Eaton Vance Senior Income Trust
EVF
$90.5M
$6.16M ﹤0.01%
968,586
SAFE
1946
Safehold
SAFE
$1.15B
$6.16M ﹤0.01%
85,163
+8,257
+11% +$538K
AMRC icon
1947
Ameresco
AMRC
$1.36B
$6.15M ﹤0.01%
117,724
-38,818
-25% -$1.67M
NNI icon
1948
Nelnet
NNI
$4.7B
$6.11M ﹤0.01%
85,727
+4,591
+6% +$310K
PGNY icon
1949
Progyny
PGNY
$2.2B
$6.1M ﹤0.01%
143,898
+791
+0.6% +$25.7K
ASB icon
1950
Associated Banc-Corp
ASB
$5.91B
$6.08M ﹤0.01%
356,856
+14,596
+4% +$222K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.